Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (39)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hibbert-Rogers, L. C. F.
Right arrow Articles by Bailey, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hibbert-Rogers, L. C. F.
Right arrow Articles by Bailey, C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1995) 36, 65-82
© 1995 The British Society for Antimicrobial Chemotherapy


research-article

Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward

Laura C. F. Hibbert-Rogersa, John Heritagea,*, Deborah M. Gascoyne-Binzia, Peter M. Hawkeya, Neil Toddb, Ian J. Lewisc and Cliff Baileyc

aDepartment of Microbiology, University of Leeds, St. James's University Hospital Leeds, UK bDepartment of Microbiology, St. James's University Hospital Leeds, UK cDepartment of Paediatric Oncology, St. James's University Hospital Leeds, UK

Received 30 September 1994; returned 19 December 1994; accepted 27 January 1995


*Correspondence to: Dr John Heritage, Department of Microbiology, University of Leeds, Leeds LS2 9JT, UK; Phone: +440-(113)-233–5592; Fax: +440-(113)-233-5649.

Between the autumn of 1989 and January 1990, 21 of the 44 children on the paediatric oncology ward of St. James's University Hospital, Leeds, UK were infected or colonised with Enterobacteriaceae producing extended-spectrum ß-lactamases. This represents 48% of the patients on the ward. Only six patients (14%) had microbiologically proven septicaemia caused by such bacteria during this period. Eighty-one isolates of Enterobacteriaceae producing extended-spectrum ß-lactamases derived from blood culture (7 isolates from 6 patients) or faecal samples (74 isolates) were available for examination. These comprised 28 Escherichia coli, 28 Klebsiella oxytoca, 11 Klebsiella pneumoniae, 10 Citrobacter freundii, 3Enterobacter spp. and 1 Serratia marcescens. Clinical isolates were resistant to penicillins and to ceftazidime. Strains isolated in this study also showed multiple resistance to a range of antimicrobial agents. Transfer to a nalidixic acid resistant laboratory strain of E. coli UB5201 was attempted, but transfer of the ceftazidime resistance determinant was only successful in 25 isolates (31%). Examination of plasmid DNA revealed sequences in each isolate that hybridised with the TEM ß-lactamase gene probe used on a variety of plasmids ranging in size from 2.5-> 150 kb, sometimes found on several replicons in a single isolate. The TEM gene probe also hybridised with chromosomal DNA in a large number of isolates. Nucleotide sequence analysis demonstrated the presence of three extended-spectrum ß-lactamases: TEM-10B produced by two isolates, TEM-12B produced by 37 isolates and TEM-26B produced by 40 isolates. In two cases, isolates producedtwo ß-lactamases, and it proved impossible to identify these enzymes unequivocally. The genes encoding TEM-10B and TEM-26B both differ from TEM-12B by single nucleotide substitutions. Analysis of the ribotype patterns derived from the clinical isolates provided evidence for cross-colonisation between patients, and this was confirmed by analysis of the plasmidprofiles. Four years after discontinuing ceftazidime and other extended-spectrum cephalosporins on this ward, patients were still colonised with bacteria that produced extended-spectrum ß-lactamases.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
P. M. Hawkey
The growing burden of antimicrobial resistance
J. Antimicrob. Chemother., September 1, 2008; 62(suppl_1): i1 - i9.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
D. L. Paterson and R. A. Bonomo
Extended-Spectrum {beta}-Lactamases: a Clinical Update
Clin. Microbiol. Rev., October 1, 2005; 18(4): 657 - 686.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
D. M. Livermore and P. M. Hawkey
CTX-M: changing the face of ESBLs in the UK
J. Antimicrob. Chemother., September 1, 2005; 56(3): 451 - 454.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
T. E. Zaoutis, M. Goyal, J. H. Chu, S. E. Coffin, L. M. Bell, I. Nachamkin, K. L. McGowan, W. B. Bilker, and E. Lautenbach
Risk Factors for and Outcomes of Bloodstream Infection Caused by Extended-Spectrum {beta}-Lactamase-Producing Escherichia coli and Klebsiella Species in Children
Pediatrics, April 1, 2005; 115(4): 942 - 949.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
X. Jiang, Y. Ni, Y. Jiang, F. Yuan, L. Han, M. Li, H. Liu, L. Yang, and Y. Lu
Outbreak of Infection Caused by Enterobacter cloacae Producing the Novel VEB-3 Beta-Lactamase in China
J. Clin. Microbiol., February 1, 2005; 43(2): 826 - 831.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
J. M. Bell, J. D. Turnidge, R. N. Jones, and the SENTRY Asia-Pacific Participants,
Prevalence of Extended-Spectrum {beta}-Lactamase-Producing Enterobacter cloacae in the Asia-Pacific Region: Results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001
Antimicrob. Agents Chemother., December 1, 2003; 47(12): 3989 - 3993.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
H. Kurokawa, N. Shibata, Y. Doi, K. Shibayama, K. Kamachi, T. Yagi, and Y. Arakawa
A New TEM-Derived Extended-Spectrum {beta}-Lactamase (TEM-91) with an R164C Substitution at the {Omega}-Loop Confers Ceftazidime Resistance
Antimicrob. Agents Chemother., September 1, 2003; 47(9): 2981 - 2983.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
K. Yamasaki, M. Komatsu, T. Yamashita, K. Shimakawa, T. Ura, H. Nishio, K. Satoh, R. Washidu, S. Kinoshita, and M. Aihara
Production of CTX-M-3 extended-spectrum {beta}-lactamase and IMP-1 metallo {beta}-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan
J. Antimicrob. Chemother., March 1, 2003; 51(3): 631 - 638.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
G. Kartali, E. Tzelepi, S. Pournaras, C. Kontopoulou, F. Kontos, D. Sofianou, A. N. Maniatis, and A. Tsakris
Outbreak of Infections Caused by Enterobacter cloacae Producing the Integron-Associated {beta}-Lactamase IBC-1 in a Neonatal Intensive Care Unit of a Greek Hospital
Antimicrob. Agents Chemother., May 1, 2002; 46(5): 1577 - 1580.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
S. Y. Essack, L. M. C. Hall, D. G. Pillay, M. L. McFadyen, and D. M. Livermore
Complexity and Diversity of Klebsiella pneumoniae Strains with Extended-Spectrum {beta}-Lactamases Isolated in 1994 and 1996 at a Teaching Hospital in Durban, South Africa
Antimicrob. Agents Chemother., January 1, 2001; 45(1): 88 - 95.
[Abstract] [Full Text]


Home page
J Antimicrob ChemotherHome page
H. Barroso, A. Freitas-Vieira, L. M. Lito, J. M. Cristino, M. J. Salgado, H. F. Neto, J. C. Sousa, G. Soveral, T. Moura, and A. Duarte
Survey of Klebsiella pneumoniae producing extended-spectrum {beta}-lactamases at a Portuguese hospital: TEM-10 as the endemic enzyme
J. Antimicrob. Chemother., May 1, 2000; 45(5): 611 - 616.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
E. Tzelepi, P. Giakkoupi, D. Sofianou, V. Loukova, A. Kemeroglou, and A. Tsakris
Detection of Extended-Spectrum beta -Lactamases in Clinical Isolates of Enterobacter cloacae and Enterobacter aerogenes
J. Clin. Microbiol., February 1, 2000; 38(2): 542 - 546.
[Abstract] [Full Text]


Home page
J. Clin. Microbiol.Home page
L. K. Siu, P.-L. Lu, P.-R. Hsueh, F. M. Lin, S.-C. Chang, K.-T. Luh, M. Ho, and C.-Y. Lee
Bacteremia Due to Extended-Spectrum beta -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae in a Pediatric Oncology Ward: Clinical Features and Identification of Different Plasmids Carrying both SHV-5 and TEM-1 Genes
J. Clin. Microbiol., December 1, 1999; 37(12): 4020 - 4027.
[Abstract] [Full Text]


Home page
J. Clin. Microbiol.Home page
D. Szabó, Z. Filetóth, J. Szentandrássy, M. Némedi, E. Tóth, C. Jeney, G. Kispál, and F. Rozgonyi
Molecular Epidemiology of a Cluster of Cases Due to Klebsiella pneumoniae Producing SHV-5 Extended-Spectrum beta -Lactamase in the Premature Intensive Care Unit of a Hungarian Hospital
J. Clin. Microbiol., December 1, 1999; 37(12): 4167 - 4169.
[Abstract] [Full Text]


Home page
Clin. Microbiol. Rev.Home page
R. Podschun and U. Ullmann
Klebsiella spp. as Nosocomial Pathogens: Epidemiology, Taxonomy, Typing Methods, and Pathogenicity Factors
Clin. Microbiol. Rev., October 1, 1998; 11(4): 589 - 603.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
K. Shannon, P. Stapleton, X. Xiang, A. Johnson, H. Beattie, F. El Bakri, B. Cookson, and G. French
Extended-Spectrum beta -Lactamase-Producing Klebsiella pneumoniae Strains Causing Nosocomial Outbreaks of Infection in the United Kingdom
J. Clin. Microbiol., October 1, 1998; 36(10): 3105 - 3110.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
J. D. D. Pitout, K. S. Thomson, N. D. Hanson, A. F. Ehrhardt, P. Coudron, and C. C. Sanders
Plasmid-Mediated Resistance to Expanded-Spectrum Cephalosporins among Enterobacter aerogenes Strains
Antimicrob. Agents Chemother., March 1, 1998; 42(3): 596 - 600.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
C. Peña, M. Pujol, C. Ardanuy, A. Ricart, R. Pallares, J. Liñares, J. Ariza, and F. Gudiol
Epidemiology and Successful Control of a Large Outbreak Due to Klebsiella pneumoniae Producing ExtendedSpectrum beta -Lactamases
Antimicrob. Agents Chemother., January 1, 1998; 42(1): 53 - 58.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.